Skip to main content
. 2020 Aug 31;142(10):100805. doi: 10.1115/1.4048028

Fig. 3.

Schematic of the lymphangions highlighting the different isolated segments for the (a) normal and (b) affected mice. The local diameter of each segment is normalized by the maximum lymphatic diameter in the ROI and plotted as D/Dmax for the (c) normal and (d) affected mice. The segment flowrate, Q*, for the (e) normal and (f) affected mice. Vertical gridlines shown in (e) and (f) denote the start and end points for the individual cycles in (g) and (h). The mean velocity, u¯, value is nondimensionalized by the max mean velocity, u¯max, and plotted for both the (g) normal and (h) affected mice. The different colors and line styles correspond to different segments and lymph velocity cycles, respectively. (i) Schematic detailing the relationships used to determine (j) a representative general velocity function for the lymph velocity cycle where u0 was calculated with respect to the right side of the curves.

Schematic of the lymphangions highlighting the different isolated segments for the (a) normal and (b) affected mice. The local diameter of each segment is normalized by the maximum lymphatic diameter in the ROI and plotted as D/Dmax for the (c) normal and (d) affected mice. The segment flowrate, Q*, for the (e) normal and (f) affected mice. Vertical gridlines shown in (e) and (f) denote the start and end points for the individual cycles in (g) and (h). The mean velocity, u¯, value is nondimensionalized by the max mean velocity, u¯max, and plotted for both the (g) normal and (h) affected mice. The different colors and line styles correspond to different segments and lymph velocity cycles, respectively. (i) Schematic detailing the relationships used to determine (j) a representative general velocity function for the lymph velocity cycle where u0 was calculated with respect to the right side of the curves.